# Contact PT-141 Telehealth: Editorial Inquiries

> Contact PT-141 Telehealth with editorial corrections or questions about our bremelanotide research summaries. We are an editorial publisher, not a clinic.

For corrections, sources, and editorial questions — not for medical or clinical requests.

## Reach the desk

Use the form below for editorial matters: a correction to something we have summarized, a peer-reviewed study you think we should read, or a question about how we cited a finding. We read every message and update the site when a correction is warranted.

Please keep in mind what we are. PT-141 Telehealth is an editorial publisher that summarizes research. We are not a clinic and cannot answer personal medical questions, recommend a dose, diagnose a condition, or help anyone obtain any substance. Questions about your own health belong with a licensed clinician who can see your full picture — not with a reading desk.

## What we can and cannot help with

We can help with: corrections to our summaries, pointers to studies we may have missed, questions about a citation or how we framed a finding, and general questions about what the published research says.

We cannot help with: personal dosing, medical advice, prescriptions, diagnosis, sourcing or buying any product, or anything that requires a clinician. If your question is about your own treatment, please speak with a qualified healthcare professional. Our role is to summarize the science accurately and keep the regulatory lines clear — nothing more.

---

A plain-English research desk for PT-141 (bremelanotide), reading the newest studies first — the one approved use named, the off-label uses flagged, the modest benefit and the nausea both kept in view; a reading desk, not a clinic, with nothing here dosed or sold.